Skip to main
  1. Stocks
  2. Envoy Medical Inc
  3. Forecast
COCH

COCH Stock Forecast & Price Target

COCH Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Envoy Medical is attractive because its fully implanted Acclaim cochlear implant has shown encouraging clinical momentum, with 12-month CNC word recognition improving to 53.2% from 39.2% at six months and 15.2% pre-implantation in the first 10 Stage 1 patients, while 9 of 10 showed a positive hearing response and no protocol-defined serious adverse events were reported. The pivotal study is advancing on schedule, with all 56 patients past three-month follow-up, the first three 12-month endpoint visits completed, and two of four PMA modules already submitted under the rolling review process. Despite modest revenue of $66K in 3Q26 and a $5.2M net loss, the company’s differentiated fully implanted design could expand cochlear implant adoption by addressing unmet need and eliminating externally worn components.

Bears say

Envoy Medical is facing a fragile liquidity position, with cash falling from $19.7M at the end of June 2026 to $14.6M at the end of September 2026 while operating cash outflows remained heavy at $(5.5M) in 2Q26 and $(5.0M) in 3Q26. The business appears reliant on external financing or warrant exercises, since outstanding Series A-1 and Series A-2 warrants could generate up to $48M of gross proceeds, yet the company may still need additional capital within the next 12 months absent those exercises. Its negative outlook is further reinforced by 7.7M Class A shares and 2.7M pre-funded warrants outstanding as of November 5, 2026, plus the risk of failing to regain NASDAQ minimum bid-price compliance by November 16, 2026.

COCH has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Envoy Medical Inc and is not a guaranteed prediction by Public.com or investment advice.

COCH Analyst Forecast & Price Prediction

Get the latest COCH stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in COCH

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Envoy Medical Inc (COCH) Forecast

Analysts have given COCH a Strong Buy based on their latest research and market trends.

According to 3 analysts, COCH has a Strong Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $15, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $15, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Envoy Medical Inc (COCH)


COCH Analyst Forecast & Price Prediction

Get the latest COCH stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in COCH

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover COCH stock data and trends